| 1H-NMR | 1H-nuclear Magnetic Resonance |
| ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide |
| AFP | alpha-fetoprotein |
| ANGPTL6 | angiopoietin-like 6 |
| AUC | area under the ROC curve |
| BCLC | Barcelona Clinic Liver Cancer |
| CCLE | Cancer Cell Line Encyclopedia |
| CLEC4G | C-type lectin domain family 4 member G |
| CLEC4M | C-type lectin domain family 4 member M |
| CYP2C9 | cytochrome P450 family 2 subfamily C member 9 |
| DAVID | Database for Annotation, Visualization, and Integrated Discovery |
| DEGs | differentially expressed genes |
| DEPs | differentially expressed proteins |
| DFS | disease-free survival |
| FC | fold change |
| FDR | false discovery rate |
| GEO | Gene Expression Ominibus |
| GEPIA | Gene Expression Profiling Interactive Analysis |
| GYS2 | glycogen synthase 2 |
| HBP21 | heat shock binding protein 21 |
| HBV | hepatitis B virus |
| HCC | hepatocellular carcinoma |
| HLM | hemostasis and lipid metabolism |
| HM450 | HumanMethylation450 BeadChip |
| HPA | Human Protein Atlas |
| HR | hazard ratio |
| IQR | interquartile range |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| LIHC | liver hepatocellular carcinoma |
| MBL2 | mannose binding lectin 2 |
| Nano-LC-MS/MS | Nanoscale Liquid Chromatography–Tandem Mass Spectrometry |
| OS | overall survival |
| PHYHD1 | phytanoyl-CoA dioxygenase domain containing 1 |
| ROC | receiver operating characteristic |
| RSEM | RNA-Seq by Expectation-Maximization |
| SLC27A5 | solute carrier family 27 member 5 |
| TAM | tumor-associated macrophages |
| TCGA | The Cancer Genome Atlas |
| TIMER | Tumor Immune Estimation Resource |
| TPM | transcripts per million |
| TTC36 | tetratricopeptide repeat domain 36 |